Enobia Pharma Inc.
7Patents
2Active
7Granted
37Portfolio score
Filing activity: Aug 23, 2001 → Jun 3, 2010 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7763712B2 | Bone delivery conjugates and method of using same to target proteins to bone | Chemistry; Metallurgy | 31 | Active |
| US7960529B2 | Bone delivery conjugates and method of using same to target proteins to bone | Chemistry; Metallurgy | 29 | Active |
| US7425531B2 | Bone polypeptide-1 | Human Necessities | 23 | Expired |
| US7399466B2 | Method and compositions for promoting osteogenesis | Physics | 23 | Expired |
| US7470668B2 | Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof | Human Necessities | 21 | Expired |
| US7105539B2 | Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex | Chemistry; Metallurgy | 20 | Expired |
| US7365091B2 | Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX | Chemistry; Metallurgy | 20 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.